Sarah Robbins
Aalborg University
10 Papers
13 Citations
Sarah Robbins is an academic researcher from Aalborg University. The author has contributed to research in topics: Disease burden & Population. The author has an hindex of 6, co-authored 9 publications. Previous affiliations of Sarah Robbins include Jhpiego & Johns Hopkins University.
Chat about Author
Papers
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
Sarah Blach,Stefan Zeuzem,Michael Manns,Ibrahim Altraif,Ann-Sofi Duberg,David H. Muljono,Imam Waked,Seyed M Alavian,Mei Hsuan Lee,Francesco Negro,Faisal Abaalkhail,Ahmed Abdou,Maheeba Abdulla,Antoine Abou Rached,Inka Aho,Ulus Salih Akarca,Imad Al Ghazzawi,Saad Al Kaabi,Faryal Al Lawati,Khalid Al Namaani,Youssif Al Serkal,Said A. Al-Busafi,Layla Al-Dabal,Soo Aleman,Abdullah S. Alghamdi,Abdulrahman Aljumah,Hamad Al-Romaihi,Monique Andersson,Vic Arendt,Perttu Arkkila,Abdullah M. Assiri,Oidov Baatarkhuu,Abate Bane,Ziv Ben-Ari,Colm Bergin,Fernando Bessone,Florian Bihl,Abdul Rahman Bizri,M. Blachier,Antonio Javier Blasco,Carlos E Brandão Mello,Philip Bruggmann,Cheryl Brunton,Filipe Calinas,Henry Lik-Yuen Chan,Asad Chaudhry,Hugo Cheinquer,Chien-Jen Chen,Rong-Nan Chien,Moon Seok Choi,Peer Brehm Christensen,Wan-Long Chuang,Vladimir Chulanov,Laura Cisneros,Mette Rye Clausen,Matthew E. Cramp,Antonio Craxì,E. A. Croes,Olav Dalgard,Jorge Daruich,Victor de Ledinghen,Gregory J. Dore,Manal H El-Sayed,Gül Ergör,Gamal Esmat,Chris Estes,Karolin Falconer,Elmoubashar Farag,Maria Lucia Gomes Ferraz,Paulo R. Ferreira,Robert Flisiak,Sona Frankova,Ivane Gamkrelidze,Edward Gane,Javier García-Samaniego,Akram Khan,Ilias Gountas,Adrian Goldis,Magnus Gottfredsson,Jason Grebely,Michael Gschwantler,Mario G. Pessoa,Jessie Gunter,Behzad Hajarizadeh,Omer Hajelssedig,Saeed Hamid,Waseem Hamoudi,Angelos Hatzakis,Sayed Himatt,Harald Hofer,Irena Hrstić,Yee Tak Hui,Béla Hunyady,Ramazan Idilman,Wasim Jafri,Rohani Jahis,Naveed Z. Janjua,Peter Jarcuska,Agita Jeruma,Jon G. Jonasson,Yasser Kamel,Jia-Horng Kao,Sabahattin Kaymakoglu,David Kershenobich,Jawad Khamis,Young Sik Kim,Loreta A. Kondili,Zaher Koutoubi,Mel Krajden,Henrik Krarup,Moon sing Lai,Wim Laleman,Wai-cheung C Lao,Daniel Lavanchy,Pablo Lázaro,Henri Leleu,Olufunmilayo A. Lesi,Laurentius A. Lesmana,Michael Li,Valentina Liakina,Young-Suk Lim,Boris Lukšić,Adam Mahomed,Matti Maimets,Mihály Makara,Abraham O. Malu,Rui Tato Marinho,Paul Marotta,Stefan Mauss,Muhammad S. Memon,Maria C Mendes Correa,Nahum Méndez-Sánchez,Shahin Merat,Ammal M. Metwally,Rosmawati Mohamed,Christophe Moreno,Fadi H. Mourad,Beat Müllhaupt,Kimberly Murphy,Helen Nde,Richard Njouom,Diana Nonković,Suzanne Norris,Solomon Obekpa,Stephen Oguche,S. Olafsson,Marian Oltman,Ogu Omede,CE Omuemu,Ohene Opare-Sem,Anne Øvrehus,Shirley Owusu-Ofori,Tsendsuren S. Oyunsuren,George V. Papatheodoridis,Ken Pasini,Kevork M. Peltekian,Richard Phillips,N. N. Pimenov,Hossein Poustchi,Nishi Prabdial-Sing,Huma Qureshi,Alnoor Ramji,Devin Razavi-Shearer,Kathryn Razavi-Shearer,Berhane Redae,Henk W. Reesink,Ezequiel Ridruejo,Sarah Robbins,Lewis R. Roberts,Stuart K. Roberts,William Rosenberg,Françoise Roudot-Thoraval,Stephen D. Ryder,Rifaat Safadi,Olga Sagalova,Riina Salupere,Faisal M. Sanai,Juan F.Sanchez Avila,Vivek A. Saraswat,Rui Sarmento-Castro,Christoph Sarrazin,Jonathan Schmelzer,Ivan Schréter,Carole Seguin-Devaux,Samir Shah,Ala I. Sharara,Manik Sharma,Anatoly Shevaldin,Gamal Shiha,William Sievert,Mark W. Sonderup,Kyriakos Souliotis,Danute Speiciene,Jan Sperl,Peter Stärkel,Rudolf E. Stauber,Catherine A.M. Stedman,Daniel Struck,Tung-Hung Su,Vana Sypsa,Soek Siam Tan,Junko Tanaka,Alexander J. Thompson,Ieva Tolmane,Krzysztof Tomasiewicz,Jonas Valantinas,Pierre Van Damme,Adriaan J. van der Meer,Ingo van Thiel,Hans Van Vlierberghe,Adriana Vince,Wolfgang Vogel,Heiner Wedemeyer,Nina Weis,Vincent Ws Wong,Cesar Yaghi,Ayman Yosry,Man-Fung Yuen,Evy Yunihastuti,Aasim Yusuf,Eli Zuckerman,Homie Razavi +221 more
TL;DR: The global estimate of viraemic HCV infections is lower than previous estimates, largely due to more recent prevalence estimates in Africa, and increased mortality due to liver-related causes and an ageing population may have contributed to a reduction in infections.
1.9K
Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study
Devin Razavi-Shearer,Ivane Gamkrelidze,Mindie H. Nguyen,Ding-Shinn Chen,Pierre Van Damme,Zaigham Abbas,Maheeba Abdulla,Antoine Abou Rached,Danjuma Adda,Inka Aho,Ulus Salih Akarca,Fuad Hasan,Faryal Al Lawati,Khalid Al Naamani,Hamad I. Al-Ashgar,Seyed M Alavian,Sameer Alawadhi,Agustín Albillos,Said A. Al-Busafi,Soo Aleman,Faleh Z. Al-Faleh,Abdulrahman Aljumah,Anil C. Anand,Nguyen Thu Anh,Joop E. Arends,Perttu Arkkila,Kostas Athanasakis,Abate Bane,Ziv Ben-Ari,Thomas Berg,Abdul Rahman Bizri,Sarah Blach,Carlos E Brandão Mello,Samantha M Brandon,Bisi Bright,Philip Bruggmann,Maurizia Rossana Brunetto,Maria Buti,Henry Lik-Yuen Chan,Asad Chaudhry,Rong-Nan Chien,Moon Seok Choi,Peer Brehm Christensen,Wan-Long Chuang,Vladimir Chulanov,Mette Rye Clausen,Massimo Colombo,Markus Cornberg,Benjamin C Cowie,Antonio Craxì,E. A. Croes,Diego Alberto Cuellar,Chris Cunningham,Hailemichael Desalegn,Sylvia Drazilova,Ann-Sofi Duberg,Steve S Egeonu,Manal H El-Sayed,Chris Estes,Karolin Falconer,Maria Lucia Gomes Ferraz,Paulo R. Ferreira,Robert Flisiak,Sona Frankova,Giovanni Battista Gaeta,Javier García-Samaniego,Jordan Genov,Jan Gerstoft,Adrian Goldis,Ilias Gountas,Richard Gray,Mario G. Pessoa,Behzad Hajarizadeh,Angelos Hatzakis,Christophe Hézode,Sayed Himatt,Andy I. M. Hoepelman,Irena Hrstić,Yee Tak Hui,Petr Husa,Rohani Jahis,Naveed Z. Janjua,Peter Jarcuska,Jerzy Jaroszewicz,Sabahattin Kaymakoglu,David Kershenobich,Loreta A. Kondili,Aliya Konysbekova,Mel Krajden,Pavol Kristian,Wim Laleman,Wai-cheung C Lao,Jen Layden,Jeffrey V. Lazarus,Mei Hsuan Lee,Valentina Liakina,Young-Suk Lim,Ching-kong K Loo,Boris Lukšić,Reza Malekzadeh,Abraham O. Malu,Adkhamjon Mamatkulov,Michael Manns,Rui Tato Marinho,Mojca Matičič,Stefan Mauss,Muhammad S. Memon,Maria C Mendes Correa,Nahum Méndez-Sánchez,Shahin Merat,Ammal M. Metwally,Rosmawati Mohamed,Jacques E Mokhbat,Christophe Moreno,Joël Mossong,Fadi H. Mourad,Beat Müllhaupt,Kimberly Murphy,Erkin Musabaev,Arif Nawaz,Helen Nde,Francesco Negro,Alexander Nersesov,Van Thi Thuy Nguyen,Richard Njouom,Renovat Ntagirabiri,Zuridin Nurmatov,Solomon Obekpa,Ponsiano Ocama,Stephen Oguche,Ogu Omede,CE Omuemu,Ohene Opare-Sem,Christopher K Opio,Necati Örmeci,George V. Papatheodoridis,Ken Pasini,N. N. Pimenov,Hossein Poustchi,Trân D Quang,Huma Qureshi,Alnoor Ramji,Kathryn Razavi-Shearer,Berhane Redae,Henk W. Reesink,Cielo Yaneth Rios,Gabriela Rjaskova,Sarah Robbins,Lewis R. Roberts,Stuart K. Roberts,Stephen D. Ryder,Rifaat Safadi,Olga Sagalova,Riina Salupere,Faisal M. Sanai,Juan Francisco Sánchez-Ávila,Vivek A. Saraswat,Christoph Sarrazin,Jonathan Schmelzer,Ivan Schréter,Julia A. Scott,Carole Seguin-Devaux,Samir Shah,Ala I. Sharara,Manik Sharma,Gamal Shiha,Tesia Shin,William Sievert,Jan Sperl,Peter Stärkel,Catherine A.M. Stedman,Vana Sypsa,Frank Tacke,Soek Siam Tan,Junko Tanaka,Krzysztof Tomasiewicz,Petr Urbánek,Adriaan J. van der Meer,Hans Van Vlierberghe,Stefano Vella,Adriana Vince,Yasir Waheed,Imam Waked,Nick Walsh,Nina Weis,Vincent Wai-Sun Wong,Joseph Woodring,Cesar Yaghi,Hwai I. Yang,Chung-Lin Yang,Kakharman Yesmembetov,Ayman Yosry,Man-Fung Yuen,Muhammed Aasim M Yusuf,Stefan Zeuzem,Homie Razavi +195 more
TL;DR: The estimate of HBV prevalence in 2016 differs from previous studies, potentially because it took into account the effect of infant prophylaxis and early childhood vaccination, as well as changing prevalence over time.
1.6K
Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study
Homie Razavi,Sarah Robbins,Stefan Zeuzem,Francesco Negro,Maria Buti,Ann-Sofi Duberg,Françoise Roudot-Thoraval,Antonio Craxì,Michael Manns,Rui Tato Marinho,Béla Hunyady,Massimo Colombo,Soo Aleman,Krasimir Antonov,Perttu Arkkila,Kostas Athanasakis,Sarah Blach,M. Blachier,Antonio Javier Blasco,Filipe Calinas,Jose Luis Calleja,Peer Brehm Christensen,Matthew E. Cramp,E. A. Croes,Robert J. de Knegt,Victor de Ledinghen,Jean-Michel Delile,Chris Estes,Karolin Falconer,Martti Färkkilä,Robert Flisiak,Sona Frankova,Ivane Gamkrelidze,Javier García-Samaniego,Jordan Genov,Jan Gerstoft,Liana Gheorghe,Adrian Goldis,Ilias Gountas,Sergeja Gregorčič,Michael Gschwantler,Jessie Gunter,Waldemar Halota,Laura Harcouet,Christophe Hézode,Patrick Hoffmann,Gabor Horvath,Irena Hrstić,Peter Jarcuska,Deian Jelev,Agita Jeruma,Martin Kåberg,Jennifer Kieran,Loreta A. Kondili,Iskren Kotzev,Henrik Krarup,Pavol Kristian,Martin Lagging,Wim Laleman,Pablo Lázaro,Valentina Liakina,Boris Lukšić,Matti Maimets,Mihály Makara,Lyudmila Mateva,Mojca Matičič,Francesco Saverio Mennini,Rumiana Mitova,Christophe Moreno,Joël Mossong,Kimberly Murphy,Helen Nde,Vratislav Nemecek,Dijana Nonkovic,Suzanne Norris,Marian Oltman,Anne Øvrehus,George V. Papatheodoridis,Ken Pasini,Devin Razavi-Shearer,Kathryn Razavi-Shearer,Henk W. Reesink,Tatjana Reic,Baiba Rozentale,Stephen D. Ryder,Riina Salupere,Rui Sarmento-Castro,Christoph Sarrazin,Jonathan Schmelzer,Ivan Schréter,Carole Seguin-Devaux,Kaarlo Simojoki,Marietta Simonova,Peter J Smit,Kyriakos Souliotis,Danute Speiciene,Jan Sperl,Peter Stärkel,Daniel Struck,Vana Sypsa,Lelia Thornton,Ieva Tolmane,Krzysztof Tomasiewicz,Jonas Valantinas,Pierre Van Damme,David A. M. C. van de Vijver,Adriaan J. van der Meer,Daniela K van Santen,Hans Van Vlierberghe,Dominique Vandijck,Stefano Vella,Jerneja Videčnik-Zorman,Wolfgang Vogel,Nina Weis,Angelos Hatzakis +114 more
TL;DR: The EU is uniquely poised to eliminate HCV; however, expansion of screening programmes is essential to increase treatment to achieve the WHO targets, and a united effort, grounded in sound epidemiological evidence, will also be necessary.
275
Eliminación de la hepatitis C en España: adaptación de un modelo matemático de salud pública partiendo del plan estratégico para el abordaje de la hepatitis C en el Sistema Nacional de Salud
Maria Buti,Jose Luis Calleja,Javier García-Samaniego,Miguel A. Serra,Javier Crespo,Manuel L. Romero,Miguel Angel Simón,Juan Turnes,Antonio Javier Blasco,Pablo Lázaro,Sarah Robbins,Homie Razavi +11 more
21
Scenarios to manage the hepatitis C disease burden and associated economic impact of treatment in Turkey
TL;DR: By implementing the WHO Targets scenario, Turkey would be able to lower HCV prevalence by 80 % and reduce the total number of liver-related deaths by >65 % by 2030 and is cost-effective if healthcare and indirect costs are taken into consideration.
10